Exela Pharma Sciences, LLC (Exela), in association with marketer X-Gen Pharmaceuticals, Inc. (X-Gen), is voluntarily recalling lot number PLND1613 of Ibuprofen Lysine Injection, 20 mg /2 mL (10 mg/mL), vials to the hospital or user level. Some of the vials have been found to contain particulate matter.